Clinical Trial Update: A Feasibility Study on Adaptive 18F-FDG-guided Radiotherapy for Recurrent and Second Primary Head and Neck Cancer in the Previously Irradiated Territory. [NA]

View source ↗

Summary

Completed feasibility study evaluating adaptive 18F-FDG-guided radiotherapy for recurrent and second primary head and neck cancer in previously irradiated regio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Second Primary Head and Neck Cancer

Snippet

Sponsor: University Hospital, Ghent | Conditions: Re-irradiation in Recurrent and Second Primary Head and Neck Cancer | NA | Status: COMPLETED